Abiopharma

News list

HAWKINS JAMES B 🟡 adjusted position in 0 shares (1 derivative) of IRADIMED CORP (IRMD) Transaction Date: Dec 11, 2025 | Filing ID: 000026

Full text

News bot Dec. 12, 2025, 10:03 p.m.
🔍 HAWKINS JAMES B (Executive)

Company: IRADIMED CORP (IRMD)

Report Date: 2025-12-11
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 905
- Total shares sold: 905
Detailed Transactions and Holdings:
- Acquired 905 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 29,647.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 905 shares of Restricted Stock Units (Derivative)
  Date: 2025-12-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 906.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Restricted stock units convert into common stock on a one-for-one basis.
- F2: On December 11, 2024, the reporting person received restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan. The restricted stock units vest in two equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.